These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 23425199)
1. Quantum mechanics/molecular mechanics modeling of fatty acid amide hydrolase reactivation distinguishes substrate from irreversible covalent inhibitors. Lodola A; Capoferri L; Rivara S; Tarzia G; Piomelli D; Mulholland A; Mor M J Med Chem; 2013 Mar; 56(6):2500-12. PubMed ID: 23425199 [TBL] [Abstract][Full Text] [Related]
2. Insights into the mechanism and inhibition of fatty acid amide hydrolase from quantum mechanics/molecular mechanics (QM/MM) modelling. Lodola A; Mor M; Sirirak J; Mulholland AJ Biochem Soc Trans; 2009 Apr; 37(Pt 2):363-7. PubMed ID: 19290863 [TBL] [Abstract][Full Text] [Related]
3. Nonempirical energetic analysis of reactivity and covalent inhibition of fatty acid amide hydrolase. Chudyk EI; Dyguda-Kazimierowicz E; Langner KM; Sokalski WA; Lodola A; Mor M; Sirirak J; Mulholland AJ J Phys Chem B; 2013 Jun; 117(22):6656-66. PubMed ID: 23654226 [TBL] [Abstract][Full Text] [Related]
4. Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure. Lodola A; Rivara S; Mor M Adv Protein Chem Struct Biol; 2011; 85():1-26. PubMed ID: 21920320 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492 [TBL] [Abstract][Full Text] [Related]
6. Understanding the role of carbamate reactivity in fatty acid amide hydrolase inhibition by QM/MM mechanistic modelling. Lodola A; Capoferri L; Rivara S; Chudyk E; Sirirak J; Dyguda-Kazimierowicz E; Andrzej Sokalski W; Mileni M; Tarzia G; Piomelli D; Mor M; Mulholland AJ Chem Commun (Camb); 2011 Mar; 47(9):2517-9. PubMed ID: 21240393 [TBL] [Abstract][Full Text] [Related]
7. The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues. Clapper JR; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D Pharmacol Res; 2006 Nov; 54(5):341-4. PubMed ID: 16935521 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells. Li H; Wood JT; Whitten KM; Vadivel SK; Seng S; Makriyannis A; Avraham HK Br J Pharmacol; 2013 Oct; 170(3):489-505. PubMed ID: 23347118 [TBL] [Abstract][Full Text] [Related]
11. Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: discovery of a deacylating water molecule and insight into enzyme inactivation. Mileni M; Kamtekar S; Wood DC; Benson TE; Cravatt BF; Stevens RC J Mol Biol; 2010 Jul; 400(4):743-54. PubMed ID: 20493882 [TBL] [Abstract][Full Text] [Related]
12. QM/MM modelling of oleamide hydrolysis in fatty acid amide hydrolase (FAAH) reveals a new mechanism of nucleophile activation. Lodola A; Mor M; Hermann JC; Tarzia G; Piomelli D; Mulholland AJ Chem Commun (Camb); 2005 Sep; (35):4399-401. PubMed ID: 16136230 [TBL] [Abstract][Full Text] [Related]
13. Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity. Ahn K; Johnson DS; Fitzgerald LR; Liimatta M; Arendse A; Stevenson T; Lund ET; Nugent RA; Nomanbhoy TK; Alexander JP; Cravatt BF Biochemistry; 2007 Nov; 46(45):13019-30. PubMed ID: 17949010 [TBL] [Abstract][Full Text] [Related]
14. Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception. Naidu PS; Booker L; Cravatt BF; Lichtman AH J Pharmacol Exp Ther; 2009 Apr; 329(1):48-56. PubMed ID: 19118134 [TBL] [Abstract][Full Text] [Related]
15. Structure-property relationships of a class of carbamate-based fatty acid amide hydrolase (FAAH) inhibitors: chemical and biological stability. Vacondio F; Silva C; Lodola A; Fioni A; Rivara S; Duranti A; Tontini A; Sanchini S; Clapper JR; Piomelli D; Mor M; Tarzia G ChemMedChem; 2009 Sep; 4(9):1495-504. PubMed ID: 19554599 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes. Alexander JP; Cravatt BF Chem Biol; 2005 Nov; 12(11):1179-87. PubMed ID: 16298297 [TBL] [Abstract][Full Text] [Related]
18. ω-Imidazolyl- and ω-Tetrazolylalkylcarbamates as Inhibitors of Fatty Acid Amide Hydrolase: Biological Activity and in vitro Metabolic Stability. Terwege T; Hanekamp W; Garzinsky D; König S; Koch O; Lehr M ChemMedChem; 2016 Feb; 11(4):429-43. PubMed ID: 26732805 [TBL] [Abstract][Full Text] [Related]
19. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment. Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915 [TBL] [Abstract][Full Text] [Related]
20. Different Routes to Inhibit Fatty Acid Amide Hydrolase: Do All Roads Lead to the Same Place? Giacovazzo G; Bisogno T; Piscitelli F; Verde R; Oddi S; Maccarrone M; Coccurello R Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]